| Gene symbol | E6 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7125..7601) | dbXrefs | |
| Description | protein E6*;transforming protein E6 | ||||
| Gene symbol | E7 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7604..7900) | dbXrefs | |
| Description | transforming protein E7 | ||||
| GTO ID | GTC2260 |
| Trial ID | NCT04180215 |
| Disease | Squamous Cell Carcinoma |
| Altered gene | E6|E7 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | HB-201 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase I/II Study of TheraT Vector(s) Expressing Human Papillomavirus 16 Positive (HPV 16+) Specific Antigens in Patients With HPV 16+ Confirmed Cancers |
| Year | 2019 |
| Country | Netherlands|Spain|United States |
| Company sponsor | Hookipa Biotech GmbH |
| Other ID(s) | H-200-001|2019-000907-34 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||